1.
Schjesvold FH, Ludwig H, Delimpasi S, Robak P, Coriu D, Tomczak W, Pour L, Spicka I, Dimopoulos M-A, Masszi T, Chernova NG, Sandberg A, Thuresson M, Norin S, Bakker NA, Mateos M-V, Richardson PG, Sonneveld P. Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study. Haematologica 2024;109(7):2331-2336; https://doi.org/10.3324/haematol.2023.284635.